← All diseases
Lungs and airways
Pulmonary fibrosis (IPF)
Would you like to receive a message when there is new research on Idiopathic Pulmonary Fibrosis (IPF)? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, above each publication you'll find one sentence explaining what was researched — and you'll receive a notification as soon as there is new research on Pulmonary Fibrosis (IPF). View what Premium costs.
Publications and studies (1944)
- Respiratory and non-respiratory symptoms in patients with IPF or sarcoidosis and controls. (2023/09/01) ♡
- Evaluation of lung protection of Sanghuangporus sanghuang through TLR4/NF-κB/MAPK, keap1/Nrf2/HO-1, CaMKK/AMPK/Sirt1, and TGF-β/SMAD3 signaling pathways mediating apoptosis and autophagy. (2023/09/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Case Report: Idiopathic pleuroparenchymal fibroelastosis. (2023/08/29) ♡
- Body mass Index does not impact long-term survival of patients with idiopathic pulmonary fibrosis undergoing lung transplantation. (2023/08/23) ♡
- Individualised Exercise Training Enhances Antioxidant Buffering Capacity in Idiopathic Pulmonary Fibrosis. (2023/08/20) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. A systematic review of the research progress of traditional Chinese medicine against pulmonary fibrosis: from a pharmacological perspective. (2023/08/03) ♡
- Geriatric Nutritional Risk Index is a predictor of tolerability of antifibrotic therapy and mortality risk in patients with idiopathic pulmonary fibrosis. (2023/08/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Unveiling the importance of evaluating the nutritional status in idiopathic pulmonary fibrosis patients with antifibrotic agent introduction. (2023/08/01) ♡
- Inhaled nintentanib, pirfenidone and macitentan for pulmonary fibrosis: a laboratory experiment. (2023/08/01) ♡
- Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. Nalbuphine Tablets for Cough in Patients with Idiopathic Pulmonary Fibrosis. (2023/08/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Managing Chronic Cough Associated with Idiopathic Pulmonary Fibrosis - Will Nalbuphine Fill an Unmet Need? (2023/08/01) ♡
- Identifying oxidative stress-related biomarkers in idiopathic pulmonary fibrosis in the context of predictive, preventive, and personalized medicine using integrative omics approaches and machine-learning strategies. (2023/07/31) ♡
- Plasma extracellular vesicle proteins as promising noninvasive biomarkers for diagnosis of idiopathic pulmonary fibrosis. (2023/07/13) ♡
- Deciphering the molecular mechanisms of Maxing Huoqiao Decoction in treating pulmonary fibrosis via transcriptional profiling and circRNA-miRNA-mRNA network analysis. (2023/07/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Short-Term Evolution of Nutritional Status in Patients with Idiopathic Pulmonary Fibrosis. (2023/07/01) ♡
- Local Pentraxin-2 Deficit Is a Feature of Intestinal Fibrosis in Crohn's Disease. (2023/07/01) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Human senescent fibroblasts trigger progressive lung fibrosis in mice. (2023/07/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Network pharmacology and molecular docking to explore the pharmacological mechanism of Yifei Tongluo granules in treating idiopathic pulmonary fibrosis: A review. (2023/06/02) ♡
- The relative contribution of co-morbidities to health-related quality of life of people with idiopathic pulmonary fibrosis using the Assessment of Quality of Life-8-Dimension multi-attribute utility instrument. (2023/06/01) ♡
- Treatment guidelineiAn official agreement between doctors about how this disease should be treated. This is not a single study but the conclusion of an entire medical field. French practical guidelines for the diagnosis and management of idiopathic pulmonary fibrosis - 2021 update. Full-length version. (2023/06/01) ♡
- Ethnographic survey of patients and caregiver's life journey in idiopathic pulmonary fibrosis. (2023/06/01) ♡
- Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Protective role of baicalin in the dynamic progression of lung injury to idiopathic pulmonary fibrosis: A meta-analysis. (2023/06/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Phase angle in assessment and monitoring treatment of individuals with respiratory disease. (2023/06/01) ♡
- Targeting TGF-β/periostin signaling by sesamol ameliorates pulmonary fibrosis and improves lung function and survival. (2023/06/01) ♡
- TIMP-1 and its potential diagnostic and prognostic value in pulmonary diseases. (2023/06/01) ♡
- Early Detection and Staging of Lung Fibrosis Enabled by Collagen-Targeted MRI Protein Contrast Agent. (2023/05/22) ♡
- Assessment of malnutrition-related risk in patients with idiopathic pleuroparenchymal fibroelastosis. (2023/05/09) ♡
- MUC5B rs35705950 minor allele associates with older age and better survival in idiopathic pulmonary fibrosis. (2023/05/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. A roadmap for developing and engineering in vitro pulmonary fibrosis models. (2023/04/28) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. A Novel CD206 Targeting Peptide Inhibits Bleomycin-Induced Pulmonary Fibrosis in Mice. (2023/04/26) ♡
- A novel corpus of molecular to higher-order events that facilitates the understanding of the pathogenic mechanisms of idiopathic pulmonary fibrosis. (2023/04/12) ♡
- Tanreqing injection protects against bleomycin-induced pulmonary fibrosis via inhibiting STING-mediated endoplasmic reticulum stress signaling pathway. (2023/04/06) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Risk of obstructive sleep apnea in idiopathic pulmonary fibrosis. (2023/04/01) ♡
- Knockdown of FBLN2 suppresses TGF-β1-induced MRC-5 cell migration and fibrosis by downregulating VTN. (2023/04/01) ♡
- Magnetic Resonance Elastography (MRE) of Bleomycin-Induced Pulmonary Fibrosis in an Animal Model. (2023/04/01) ♡
- A silent march-Post covid fibrosis in asymptomatics - A cause for concern? (2023/04/01) ♡
- A 1-year follow-up study in patients with idiopathic pulmonary fibrosis regarding adverse outcomes to unintended weight loss. (2023/04/01) ♡
- Study on the relationship between selenium and cadmium in diseased human lungs. (2023/04/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Role of vitamin D3 in selected pulmonary diseases with particular emphasis on lung fibrosis. (2023/03/31) ♡
- Invasive aspergillosis mimicking cryptogenic organizing pneumonia in a patient with diffuse large B-cell lymphoma. (2023/03/29) ♡
- S1PR1 serves as a viable drug target against pulmonary fibrosis by increasing the integrity of the endothelial barrier of the lung. (2023/03/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Viewpoint: a multidisciplinary approach to the assessment of patients with systemic sclerosis-associated interstitial lung disease. (2023/03/01) ♡
- Differences in Treatment Response in Bronchial Epithelial Cells from Idiopathic Pulmonary Fibrosis (IPF) Patients: A First Step towards Personalized Medicine? (2023/02/10) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Idiopathic pulmonary fibrosis and intestinal disorders: An observational study. (2023/02/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Diverse functions of apolipoprotein A-I in lung fibrosis. (2023/02/01) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Thymol protects against bleomycin-induced pulmonary fibrosis via abrogation of oxidative stress, inflammation, and modulation of miR-29a/TGF-β and PI3K/Akt signaling in mice. (2023/02/01) ♡
- The matricellular protein CCN3 supports lung endothelial homeostasis and function. (2023/02/01) ♡
- PM(2.5) and constituent component impacts on global DNA methylation in patients with idiopathic pulmonary fibrosis. (2023/02/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. A rare cause of pulmonary hypertension: Idiopathic fibrosing mediastinitis obstructing right pulmonary artery and pulmonary veins. (2023/02/01) ♡
- Regional and disease specific human lung extracellular matrix composition. (2023/02/01) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.